Amino Acid Substitutions at Position 69 of the Reverse Transcriptase of Human Immunodeficiency Virus Type 1 Are Frequent in Zalcitabine-Naive Antiretroviral-Drug-Experienced Patients
Open Access
- 1 September 2002
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 46 (9) , 3110-3111
- https://doi.org/10.1128/aac.46.9.3110-3111.2002
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Prevalence of the mutational pattern E44D/A and/or V118I in the reverse transcriptase (RT) gene of HIV-1 in relation to treatment with nucleoside analogue RT inhibitors.Journal of Medical Virology, 2002
- Variants Other than Aspartic Acid at Codon 69 of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Gene Affect Susceptibility to Nucleoside AnalogsAntimicrobial Agents and Chemotherapy, 2001
- Patterns of Resistance Mutations to Antiretroviral Drugs in Extensively Treated HIV-1–Infected Patients With Failure of Highly Active Antiretroviral TherapyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapyJournal of Virology, 1996
- Human immunodeficiency virus type 1 pol gene mutations which cause decreased susceptibility to 2',3'-dideoxycytidineAntimicrobial Agents and Chemotherapy, 1992